Online citations, reference lists, and bibliographies.

Interaction Of Calcium Channel Blockers And Grapefruit Juice In Healthy Adults

S. Kannan, N. Gogtay, U. Thatte
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1046/J.1365-2125.1999.00052.X
Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
V. Eagling (1999)
10.1007/BF03189827
Interaction between grapefruit juice and diazepam in humans
M. Özdemir (2010)
10.3928/0147-7447-20050701-04
What's the scoop with grapefruit?
E. Sterling (2005)
10.1172/JCI116064
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.
J. Kolars (1992)
10.4065/75.9.933
Drug-grapefruit juice interactions.
G. Kane (2000)
10.1136/bmj.315.7109.629
Bias in meta-analysis detected by a simple, graphical test
M. Egger (1997)
10.1172/JCI119439
Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
K. Lown (1997)
10.1111/j.1524-6175.2006.04482.x
Calcium Channel Blocker Class Heterogeneity: Select Aspects of Pharmacokinetics and Pharmacodynamics
D. Sica (2005)
10.1248/BPB.21.1062
Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
H. Takanaga (1998)
10.1038/sj.ejcn.1601736
Food–drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance
A. Dahan (2004)
10.1007/s002280000156
Effect of grapefruit juice dose on grapefruit juice–triazolam interaction: repeated consumption prolongs triazolam half-life
Jari J. Lilja (2000)
Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.
D. Bailey (1995)
10.1136/bmj.b2700
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
A. Liberati (2009)
10.1186/1475-2891-6-33
Medicinal importance of grapefruit juice and its interaction with various drugs
Jawad Kiani (2007)
10.1136/bmj.f1
Drug-grapefruit juice interactions
M. Pirmohamed (2013)
10.1111/j.1524-6175.2005.04140.x
Pharmacotherapy Review: Calcium Channel Blockers
D. Sica (2006)
Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
D. Edwards (1996)
10.1093/ajhp/40.10.1798
Update on calcium-channel blocking agents.
R. Talbert (1983)
10.1111/J.1365-2125.2006.02583.X
Effect of grapefruit juice on the disposition of manidipine enantiomers in healthy subjects.
T. Uno (2006)
Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.
A. Miniscalco (1992)
10.1111/J.1365-2125.2006.02636.X
Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists.
A. Ohnishi (2006)
Nutrient content and nutrition labeling of several processed Florida citrus juice products.
P. Fellers (1990)
10.1038/clpt.1993.195
Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics
D. Bailey (1993)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar